BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 28, 2011
 |  BC Week In Review  |  Company News  |  Deals

Proacta, Yakult deal

Proacta granted Yakult Honsha exclusive rights to cancer candidate PR509 in Japan. The partners will complete preclinical and Phase I trials of the compound in the U.S. after which Yakult can exercise the...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >